Corinne Johnson Stock Analyst Profile - Goldman Sachs Research Coverage - Stocknear

Corinne Johnson

Stock Analyst at Goldman Sachs

(4.1)
# 1931
Out of 5,459 analysts
12
Total ratings
Success rate
Average return
7 Stocks
Name Action PT Current % Upside Ratings Updated
RNA Avidity Biosciences
Reinstates: Buy
55
47.82 15.01% 2 Jul 10, 2025
AVBP ArriVent BioPharma
Reinstates: Buy
33
19.21 71.79% 3 Jul 10, 2025
AMLX Amylyx Pharmaceutica...
Reinstates: Buy
10
9.45 5.82% 1 Jul 10, 2025
SNDX Syndax Pharmaceutica...
Initiates Coverage On: Buy
18
16.26 10.7% 1 Jul 10, 2025
NBIX Neurocrine Bioscienc...
Initiates Coverage On: Buy
182
138.13 31.76% 1 Jul 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
43 50
26.48 88.82% 3 May 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
50
15.18 229.38% 1 Mar 13, 2024